Trial: 201612005

A Phase 1b/2 Trial of Hu5F9-G4 in Combination with
Rituximab or Rituximab + Chemotherapy in Patients
with Relapsed/Refractory B-cell Non-Hodgkin’s
Lymphoma

Phase

I/II

Principal Investigator

Bartlett, Nancy

Disease Site

Lymphoid Leukemia; Non-Hodgkin’s Lymphoma

Learn more about this study at: clinicaltrials.gov